The tumor weight in YM101 treatment group was significantly lower compared with vehicle (p < 0.001), anti-TGF-β (p < 0.001), and anti-PD-L1 (p < 0.01) groups (Fig. 6e). Here, TGFB1 is linked to neoplasm.